Treatment for high prolactin caused by antipsychotic medicines
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests a medicine called carbergoline to see if it can safely lower high prolactin levels caused by antipsychotic drugs. It may help reduce symptoms like breast discomfort or missed periods, and improve well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on an antipsychotic medicine for at least 3 months.
- You have high prolactin levels that are caused by your antipsychotic medicine.
- You must not have tried or failed a similar dopamine agonist treatment before.
- You must not use recreational drugs that can increase prolactin.
- You must not have current suicidal thoughts at the time of joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether pramipexole, a medication that may boost dopamine activity, helps improve symptoms of depression and loss of interest (anhedonia) in people with bipolar disorder. Participants will receive either pramipexole or a placebo (inactive pill) to see if it helps.
This trial compares two medications, cabergoline and bromocriptine, to see which works better for women with high prolactin levels (hyperprolactinemia). It aims to find a more effective treatment to help manage this condition, which can affect fertility and menstrual cycles.
This trial tests a higher dose of the drug cabergoline to see if it works better for small prolactin-secreting tumors (microprolactinomas) in premenopausal women who have not been treated before. It aims to find a safe and effective way to lower high prolactin levels and shrink the tumor.
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
This trial tests if cabergoline, a medicine, can help shrink nonfunctioning pituitary adenomas (benign tumors on the pituitary gland that don't produce excess hormones). It may be an option for people who have not had prior radiation or surgery, and whose tumors are at least 0.5 cm in size.
This study tests whether a medication called cabergoline can help stop milk production and reduce breast discomfort after a pregnancy loss or abortion.
Hear when a new Scizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.